In our study, we showed that TMEM43 expression levels were higher in pancreatic cancer samples than in control samples, and pancreatic cancer patients with higher TMEM43 expression levels had shorter OS and DFS. This evidence concerns the gene TMEM43 and familial pancreatic carcinoma.